Last reviewed · How we verify
Firsekibart
At a glance
| Generic name | Firsekibart |
|---|---|
| Sponsor | Ruijin Hospital |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus (PHASE4)
- A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |